Glycosylation diseases: quo vadis?
暂无分享,去创建一个
[1] F. Muntoni,et al. The modulation of skeletal muscle glycosylation as a potential therapeutic intervention in muscular dystrophies. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[2] J. Percival,et al. Golgi Complex Organization in Skeletal Muscle: A Role for Golgi‐Mediated Glycosylation in Muscular Dystrophies? , 2007, Traffic.
[3] L. Sangiorgi,et al. Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. , 2008, American journal of human genetics.
[4] A. Kastaniotis,et al. Human RFT1 deficiency leads to a disorder of N-linked glycosylation. , 2008, American journal of human genetics.
[5] Ron A Wevers,et al. A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: the biochemical characteristics. , 2005, Biochimica et biophysica acta.
[6] H. Narimatsu. α3/4-Fucosyltransferase (FUT3, Lewis enzyme) , 2002 .
[7] H. Freeze,et al. Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy. , 2006, Biochimica et biophysica acta.
[8] R. Wevers,et al. Congenital disorder of glycosylation type Ix: Review of clinical spectrum and diagnostic steps , 2008, Journal of Inherited Metabolic Disease.
[9] H. Schachter,et al. Congenital disorders involving defective N-glycosylation of proteins , 2001, Cellular and Molecular Life Sciences CMLS.
[10] Y. Wada. Mass spectrometry for congenital disorders of glycosylation, CDG. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[11] Markus Aebi,et al. Altered glycan structures: the molecular basis of congenital disorders of glycosylation. , 2005, Current Opinion in Structural Biology.
[12] R. Wevers,et al. COBBLESTONE-LIKE BRAIN DYSGENESIS AND ALTERED GLYCOSYLATION IN CONGENITAL CUTIS LAXA, DEBRÉ TYPE , 2009, Neurology.
[13] Y. Matsuzawa,et al. Aberrant Glycosylation of E-cadherin Enhances Cell-Cell Binding to Suppress Metastasis* , 1996, The Journal of Biological Chemistry.
[14] M. Mäki,et al. Peters’-plus syndrome is a congenital disorder of glycosylation caused by a defect in the β1,3-glucosyltransferase that modifies thrombospondin type 1 repeats , 2009, Annals of medicine.
[15] H. Freeze,et al. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[16] Sumana Sanyal,et al. Does Rft1 flip an N-glycan lipid precursor? , 2008, Nature.
[17] H. Schachter. Protein glycosylation lessons from Caenorhabditis elegans. , 2004, Current opinion in structural biology.
[18] V. Reinhold,et al. Null Mutations in Drosophila N-Acetylglucosaminyltransferase I Produce Defects in Locomotion and a Reduced Life Span* , 2006, Journal of Biological Chemistry.
[19] P. Clayton,et al. Defective galactosylation of serum transferrin in galactosemia. , 1998, Glycobiology.
[20] W. Tanner,et al. Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. , 2006, Angewandte Chemie.
[21] H. Freeze,et al. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. , 2000, The American journal of pathology.
[22] H. Freeze,et al. The congenital disorders of glycosylation: A multifaceted group of syndromes , 2006, NeuroRX.
[23] H. Freeze,et al. Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with Congenital Disorders of Glycosylation (CDG). , 2000, Glycobiology.
[24] S. Tuft,et al. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy. , 2002, Investigative ophthalmology & visual science.
[25] R. Roberto,et al. Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes. , 2003, Blood cells, molecules & diseases.
[26] O. Bohorov,et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.
[27] Gert Matthijs,et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.
[28] Naoyuki Taniguchi,et al. Decoding sugar functions by identifying target glycoproteins. , 2006, Current opinion in structural biology.
[29] H. Narimatsu. α3-Fucosyltransferase-IV (FUT4) , 2002 .
[30] Paul T Martin,et al. The dystroglycanopathies: the new disorders of O-linked glycosylation. , 2005, Seminars in pediatric neurology.
[31] K. White,et al. Two novel GALNT3 mutations in familial tumoral calcinosis , 2007, American journal of medical genetics. Part A.
[32] J. Gilbert,et al. Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland. , 2000, Molecular vision.
[33] R Apweiler,et al. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.
[34] R. Cummings,et al. Protein glycosylation: Chaperone mutation in Tn syndrome , 2005, Nature.
[35] H. Narimatsu,et al. Bioinformatics for comprehensive finding and analysis of glycosyltransferases. , 2006, Biochimica et biophysica acta.
[36] C. Walsh,et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.
[37] J. Gécz,et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. , 2008, American journal of human genetics.
[38] S. Mundlos,et al. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[40] H. Freeze,et al. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) , 2000, The Journal of clinical investigation.
[41] E. Berger,et al. β3-Galactosyltransferase-I, -II, and -III , 2002 .
[42] A. Varki,et al. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. , 1981, The Journal of clinical investigation.
[43] Naoyuki Taniguchi,et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Marth,et al. Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.
[45] R. Rampal,et al. Notch signaling in normal and disease States: possible therapies related to glycosylation. , 2007, Current molecular medicine.
[46] E. Traboulsi,et al. Etiology of Vision Loss in Ganglioside GM3 Synthase Deficiency , 2006, Ophthalmic genetics.
[47] R. Krishna,et al. Post-translational modification of proteins. , 1993, Advances in enzymology and related areas of molecular biology.
[48] Gert Matthijs,et al. Deficiencies in subunits of the Conserved Oligomeric Golgi (COG) complex define a novel group of Congenital Disorders of Glycosylation. , 2008, Molecular genetics and metabolism.
[49] H. Freeze,et al. COG8 deficiency causes new congenital disorder of glycosylation type IIh. , 2007, Human molecular genetics.
[50] A. Fritz,et al. A beta1,4-galactosyltransferase is required for convergent extension movements in zebrafish. , 2006, Developmental biology.
[51] J. Esko,et al. Hereditary multiple exostoses and heparan sulfate polymerization. , 2002, Biochimica et biophysica acta.
[52] H. Freeze,et al. Deficiency of UDP‐GlcNAc:Dolichol Phosphate N‐Acetylglucosamine‐1 Phosphate Transferase (DPAGT1) Causes a Novel Congenital Disorder of Glycosylation Type Ij , 2003, Human mutation.
[53] M. Fukuda,et al. Molecular and cellular glycobiology , 2000 .
[54] M. Zaffanello,et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. , 2005, Glycobiology.
[55] S. Kornfeld. Trafficking of lysosomal enzymes in normal and disease states. , 1986, The Journal of clinical investigation.
[56] H. Kurahashi,et al. Fukutin and alpha-dystroglycanopathies. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[57] N. Callewaert,et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Robertson,et al. Spondyloepiphyseal dysplasia, Omani type: Further definition of the phenotype , 2008, American journal of medical genetics. Part A.
[59] D. Behar,et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis , 2004, Nature Genetics.
[60] H. Narimatsu. Human glycogene cloning: focus on β3-glycosyltransferase and β4-glycosyltransferase families , 2006 .
[61] H. Freeze,et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. , 1998, The Journal of clinical investigation.
[62] T. Hamamoto,et al. ST3Gal-II (SAT-IV) , 2002 .
[63] W. Tanner,et al. Protein Glycosylation, Conserved from Yeast to Man: A Model Organism Helps Elucidate Congenital Human Diseases , 2007 .
[64] H. Schachter,et al. N-glycans are involved in the response of Caenorhabditis elegans to bacterial pathogens. , 2006, Methods in enzymology.
[65] H. Freeze. Editorial [Hot Topic: Novel Perspectives on Glycosylation and Human Disease (Guest Editor: Hudson H. Freeze)] , 2007 .
[66] H. Heimpel,et al. Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? , 2000, Haematologica.
[67] K. Campbell,et al. LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies , 2004, Nature Medicine.
[68] A. Seppo,et al. Induction of neuron-specific glycosylation by Tollo/Toll-8, a Drosophila Toll-like receptor expressed in non-neural cells , 2003, Development.
[69] A. Fritz,et al. A β1,4-galactosyltransferase is required for Bmp2-dependent patterning of the dorsoventral axis during zebrafish embryogenesis , 2006, Development.
[70] J. Jaeken,et al. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI‐TOF MS , 2008, Proteomics.
[71] Paul T. Martin. Mechanisms of Disease: congenital muscular dystrophies—glycosylation takes center stage , 2006, Nature Clinical Practice Neurology.
[72] J. Hewitt,et al. Glycosylation defects: a new mechanism for muscular dystrophy? , 2003, Human molecular genetics.
[73] I. Nishino,et al. Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy? , 2007, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[74] J. Marth,et al. Cellular and molecular analysis of neural development of glycosyltransferase gene knockout mice. , 2006, Methods in enzymology.
[75] J. Boulter,et al. The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands , 2005, The Journal of cell biology.
[76] M. Krieger,et al. Retrograde transport on the COG railway. , 2006, Trends in cell biology.
[77] H. Freeze,et al. Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. , 1996, The Journal of clinical investigation.
[78] J. Denecke,et al. A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. , 2007, American journal of human genetics.
[79] Hudson H. Freeze,et al. Genetic defects in the human glycome , 2006, Nature Reviews Genetics.
[80] H. Schachter. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. , 1986, Advances in experimental medicine and biology.
[81] J. Vajsar,et al. Walker-Warburg syndrome , 2006, Orphanet journal of rare diseases.
[82] Paul T Martin,et al. Congenital muscular dystrophies involving the O-mannose pathway. , 2007, Current molecular medicine.
[83] H. Freeze,et al. Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation , 1997, The Journal of Biological Chemistry.
[84] Ron A Wevers,et al. Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. , 2006, Clinical chemistry.
[85] M. Krieger,et al. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. , 2007, Human molecular genetics.
[86] Gert Matthijs,et al. Congenital disorders of glycosylation: a rapidly expanding disease family. , 2007, Annual review of genomics and human genetics.
[87] N. Shaper,et al. β4-Galactosyltransferase-I , 2002 .
[88] H. Narimatsu. Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. , 2006, Current opinion in structural biology.
[89] H. Clausen,et al. β4-Galactosyltransferase-II, -III, -IV, -V, -VI, and -VII , 2002 .
[90] K. Furukawa,et al. Galactosyltransferase I is a gene responsible for progeroid variant of Ehlers-Danlos syndrome: molecular cloning and identification of mutations. , 2002, Biochimica et biophysica acta.
[91] R. Oriol,et al. α2-Fucosyltransferases (FUT1,FUT2, and Sec1) , 2002 .
[92] D. Sillence,et al. Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. , 2006, American journal of human genetics.
[93] E. Thonar,et al. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene , 2000, Nature Genetics.
[94] J. Marth,et al. A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.
[95] P. Beck‐Peccoz,et al. Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis , 2007, Journal of Human Genetics.
[96] Friedrich Altmann,et al. The Drosophila fused lobes Gene Encodes an N-Acetylglucosaminidase Involved in N-Glycan Processing* , 2006, Journal of Biological Chemistry.
[97] H. Schachter. Coordination between enzyme specificity and intracellular compartmentation in the control of protein‐bound oligosaccharide biosynthesis , 1984, Biology of the cell.
[98] Y. Sunada,et al. Fukuyama‐type congenital muscular dystrophy (FCMD) and α‐dystroglycanopathy , 2003 .
[99] H. Freeze. Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond. , 2007, Current molecular medicine.
[100] Sumana Sanyal,et al. Distinct Flippases Translocate Glycerophospholipids and Oligosaccharide Diphosphate Dolichols across the Endoplasmic Reticulum† , 2008, Biochemistry.
[101] M. Huynen,et al. POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005, Journal of Medical Genetics.
[102] R. Kannagi. α3-Fucosyltransferase-VI (FUT6) , 2002 .
[103] H. Freeze,et al. Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy* , 2006, Journal of Biological Chemistry.
[104] Wenli Zhang,et al. The role of defective glycosylation in congenital muscular dystrophy , 2003, Glycoconjugate Journal.
[105] R. Dwek,et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.
[106] C. Costello,et al. srf-3, a Mutant of Caenorhabditis elegans, Resistant to Bacterial Infection and to Biofilm Binding, Is Deficient in Glycoconjugates* , 2004, Journal of Biological Chemistry.
[107] H. Ropers,et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. , 2008, American journal of human genetics.
[108] J. Dennis,et al. Suppression of tumor growth and metastasis in Mgat5-deficient mice , 2000, Nature Medicine.
[109] M. Fukuda. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test. , 1999, Biochimica et Biophysica Acta.
[110] P. Gasparini,et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. , 1997, American journal of human genetics.
[111] T. Kinoshita,et al. Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria. , 1995, Advances in immunology.